لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Malladi RK; California State University Dominguez Hills, Carson, CA USA.

المصدر: Computational economics [Comput Econ] 2022 Oct 26, pp. 1-25. Date of Electronic Publication: 2022 Oct 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 101721416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1572-9974 (Electronic) Linking ISSN: 09277099 NLM ISO Abbreviation: Comput Econ

المؤلفون: Finazzi MC; Haematology and Bone Marrow Transplant Unit, Azienda Socio Sanitaria Papa Giovanni XXIII, Bergamo, Italy.; Department of Oncology and Haematology, Università degli Studi di Milano, Milan, Italy., Boschini C; Haematology and Bone Marrow Transplant Unit, Azienda Socio Sanitaria Papa Giovanni XXIII, Bergamo, Italy., Craddock C; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK.; University of Birmingham, Birmingham, UK., Rambaldi A; Department of Oncology and Haematology, Università degli Studi di Milano, Milan, Italy., Ward J; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK.; University of Birmingham, Birmingham, UK., Malladi RK; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK.; University of Birmingham, Birmingham, UK.

المصدر: British journal of haematology [Br J Haematol] 2020 Feb; Vol. 188 (4), pp. 550-559. Date of Electronic Publication: 2019 Nov 12.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Graft vs Host Disease*/mortality , Graft vs Host Disease*/therapy , Hematopoietic Stem Cell Transplantation* , Transplantation Conditioning*, Alemtuzumab/*administration & dosage, Acute Disease ; Adolescent ; Adult ; Aged ; Allografts ; Chronic Disease ; Disease-Free Survival ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Organ Specificity ; Retrospective Studies ; Risk Factors ; Survival Rate ; Unrelated Donors

المؤلفون: Douglas KW; Clinical Apheresis Unit, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Gilleece M; Yorkshire Blood and Marrow Transplant Programme, Leeds Teaching Hospitals, Leeds, United Kingdom., Hayden P; Haematology Department, St James's Hospital, Dublin, Ireland., Hunter H; Haematology Department, Derriford Hospital, Plymouth Hospitals NHS Trust, Plymouth, United Kingdom., Johnson PRE; Department of Haematology, Western General Hospital, Edinburgh, United Kingdom., Kallmeyer C; Department of Haematology, Lincoln County Hospital, United Lincolnshire Hospitals NHS Trust, Lincoln, United Kingdom., Malladi RK; Centre for Clinical Haematology, University Hospitals Birmingham, Birmingham, United Kingdom., Paneesha S; Department of Haematology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom., Pawson R; Tissue Services and Cell Banking, NHS Blood and Transplant, Bristol, United Kingdom., Quinn M; Department of Haematology, Belfast NHS Trust, Belfast, United Kingdom., Raj K; Haematological Cancer Services, King's College Hospital NHS Foundation Trust, London, United Kingdom., Richardson D; Department of Haematology, University Hospital Southampton, Southampton, United Kingdom., Robinson S; Bristol Haematology Unit, University Hospitals Bristol, Bristol, United Kingdom., Russell N; Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom., Snowden J; Department of Haematology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Sureda A; Department of Haematology, Institut Catalá d'Oncologia, Barcelona, Spain., Tholouli E; HSC Transplant Services, Department of Haematology, Central Manchester University Hospitals, Manchester, United Kingdom., Thomson K; Department of Clinical Haematology, University College Hospitals, London, United Kingdom., Watts M; Wolfson Cellular Therapies Unit, University College Hospitals, London, United Kingdom., Wilson KM; Department of Haematology, Cardiff & Vale University Health Board, Cardiff, United Kingdom.

المصدر: Journal of clinical apheresis [J Clin Apher] 2018 Feb; Vol. 33 (1), pp. 46-59. Date of Electronic Publication: 2017 Jun 20.

نوع المنشور: Journal Article; Multicenter Study; Review

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8216305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1101 (Electronic) Linking ISSN: 07332459 NLM ISO Abbreviation: J Clin Apher Subsets: MEDLINE

مواضيع طبية MeSH: Consensus*, Chemoradiotherapy/*methods , Hematopoietic Stem Cell Mobilization/*methods , Heterocyclic Compounds/*therapeutic use , Neoplasms/*drug therapy, Benzylamines ; Cyclams ; Hematopoietic Stem Cell Mobilization/economics ; Heterocyclic Compounds/economics ; Humans ; Neoplasms/therapy ; Peripheral Blood Stem Cell Transplantation/methods ; Peripheral Blood Stem Cells/drug effects ; Premedication ; Transplantation, Autologous ; United Kingdom

المؤلفون: Alfred A; Rotherham Foundation NHS Trust, Rotherham, UK., Taylor PC; Rotherham Foundation NHS Trust, Rotherham, UK., Dignan F; Central Manchester NHS Foundation Trust, Manchester, UK., El-Ghariani K; Therapeutics and Tissue Services, NHS Blood and Transplant, Sheffield, UK., Griffin J; University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Gennery AR; Institute of Cellular Medicine, Newcastle University and Great North Children's Hospital, Newcastle-Upon-Tyne, UK., Bonney D; Royal Manchester Children's Hospital, Manchester, UK., Das-Gupta E; Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK., Lawson S; Birmingham Childrens Hospital, Birmingham, UK., Malladi RK; University Hospitals Birmingham NHS Trust, Birmingham, UK., Douglas KW; Beatson West of Scotland Cancer Centre, Clinical Apheresis Unit., Maher T; Rotherham Foundation NHS Trust, Rotherham, UK., Guest J; Institute of Cellular Medicine, Newcastle University and Great North Children's Hospital, Newcastle-Upon-Tyne, UK., Hartlett L; Birmingham Childrens Hospital, Birmingham, UK., Fisher AJ; Institute of Transplantation, Newcastle University and Freeman Hospital, Newcastle-upon-Tyne, UK., Child F; St John's Institute of Dermatology, Guy's and St Thomas' Hospital, London, UK., Scarisbrick JJ; University Hospitals Birmingham NHS Trust, Birmingham, UK.

المصدر: British journal of haematology [Br J Haematol] 2017 Apr; Vol. 177 (2), pp. 287-310. Date of Electronic Publication: 2017 Feb 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Graft Rejection/*therapy , Graft vs Host Disease/*therapy , Lymphoma, T-Cell, Cutaneous/*therapy , Photopheresis/*methods, Consensus ; Humans ; United Kingdom

المؤلفون: Malladi RK; Department of Haematology, John Radcliffe Hospital, Oxford, UK. ram.malladi@ndcls.ox.ac.uk, Peniket AJ, Littlewood TJ, Towlson KE, Pearce R, Yin J, Cavenagh JD, Craddock C, Orchard KH, Olavarria E, McQuaker G, Collin M, Marks DI

مؤلفون مشاركون: British Society of Blood and Marrow Transplantation

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2009 May; Vol. 43 (9), pp. 709-15. Date of Electronic Publication: 2008 Nov 24.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antibodies, Neoplasm/*therapeutic use , Graft vs Host Disease/*drug therapy , Hematopoietic Stem Cell Transplantation/*methods , Leukemia, Myeloid, Acute/*therapy , Transplantation Conditioning/*methods, Adolescent ; Adult ; Aged ; Alemtuzumab ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/therapeutic use ; Chronic Disease ; Drug Evaluation ; Female ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; In Vitro Techniques ; Leukemia, Myeloid, Acute/complications ; Leukemia, Myeloid, Acute/mortality ; Lymphocyte Depletion/methods ; Middle Aged ; Registries ; Retrospective Studies ; Siblings ; Survival Rate ; Transplantation Conditioning/mortality ; Transplantation, Homologous ; Young Adult